Frontpage » Partners » American Society for Radiation Oncology

American Society for Radiation Oncology

ASTRO and AUA issue joint guideline for radiation therapy after prostatectomy

The American Society for Radiation Oncology (ASTRO) and the American Urological Association (AUA) are pleased to announce the publication of the joint guideline on radiation therapy after prostatectomy for patients with and ...

Cancer May 07, 2013 | not rated yet | 0

New ASTRO white paper recommends best practices to improve safety and effectiveness of IGRT

The American Society for Radiation Oncology (ASTRO) has issued a new white paper, "Assuring Safety and Quality in Image Guided Delivery of Radiation Therapy," that recommends best practices to improve the safety and effectiveness ...

Cancer Apr 18, 2013 | not rated yet | 0

New ASTRO white paper recommends peer review to increase quality assurance and safety

The American Society for Radiation Oncology (ASTRO) has issued a new white paper, "Enhancing the role of case-oriented peer review to improve quality and safety in radiation oncology: Executive Summary," that recommends increased ...

Cancer Mar 21, 2013 | not rated yet | 0

CT texture analysis of tumors may be a valuable biomarker in localized esophageal cancer

CT texture analysis of primary tumors may be a potential imaging biomarker in localized esophageal cancer following neoadjuvant chemotherapy, according to research being presented at the 2013 Cancer Imaging and Radiation ...

Cancer Feb 08, 2013 | not rated yet | 0

DAI provides potential imaging biomarker to indicate brain tumor response to RT

Diffusion abnormality index (DAI) shows promise as an imaging biomarker to measure brain tumor response to radiation therapy, according to research being presented at the 2013 Cancer Imaging and Radiation Therapy Symposium. ...

Cancer Feb 08, 2013 | not rated yet | 0

SUVmax provides valuable indicator of progression-free survival in stage I NSCLC patients

SUVmax (Maximum Standardized Uptake Value) may be a significant and clinically independent marker to indicate progression-free survival in stage I non-small cell lung cancer (NSCLC) patients treated with stereotactic body ...

Cancer Feb 08, 2013 | not rated yet | 0

Hepatic function testing can assist in treatment planning for liver cancer patients

Monitoring the hepatic function of unresectable liver cancer patients, measured by 99mTc-labeled iminodiacetic acid (HIDA) via single-photon emission computed tomography (SPECT) prior to and during radiation therapy, provides ...

Cancer Feb 08, 2013 | not rated yet | 0

Predicting erectile dysfunction from prostate cancer treatment

Researchers have identified 12 DNA sequences that may help doctors determine which men will suffer from erectile dysfunction (ED) following radiation therapy for prostate cancer. Identifying these patients in advance of treatment ...

Cancer Sep 27, 2012 | not rated yet | 0

Crizotinib reduces tumor size in patients with ALK positive lung cancer

Crizotinib is effective in shrinking tumors in patients with anaplastic lymphoma receptor tyrosine kinase (ALK) positive non-small cell lung cancer, a cancer commonly found in people who never smoked, and should be the standard ...